Kaplan Fox Encourages GPGI, Inc. (NYSE: GPGI) Investors to Contact the Firm Before the Deadline on September 14, 2026

Kaplan Fox announced a securities class action against GPGI, formerly CompoSecure, covering investors who bought Class A shares between November 3, 2025 and May 6, 2026. The complaint alleges the company overstated Husky Technologies' value and the benefits of its acquisition, which closed January 12, 2026, to obtain shareholder approval and PIPE financing while generating additional management fees. Investors seeking lead-plaintiff status must apply by September 14, 2026; the allegations remain unproven.

Analysis

This is a litigation-advertising notice rather than an adjudicated finding, so it is not independently informative on damages or liability. The actionable issue is whether the lawsuit surfaces previously undisclosed acquisition-model weaknesses: Husky purchase-accounting adjustments, impaired goodwill/intangibles, weaker-than-underwritten volume, or leverage/covenant pressure. Until then, any headline-driven GPGI weakness is more likely a liquidity and governance-risk discount than a durable change to earnings power.

Near term (days to weeks), the September 14 lead-plaintiff deadline is unlikely to be a catalyst; securities suits commonly follow a material drawdown and rarely alter fundamentals at filing. The more relevant 1-3 month catalyst is the next earnings release and any revised disclosure around acquisition synergies, integration costs, customer concentration, or debt-service coverage. A failure to reaffirm Husky-related EBITDA/FCF targets would turn the legal claim into an operational credibility problem and could trigger further multiple compression.

The 6-18 month risk is that management incentives and deal process become a financing-cost issue rather than a one-time legal expense. If governance concerns raise the equity-risk premium while the combined company carries meaningful acquisition debt, refinancing flexibility deteriorates disproportionately; that can constrain capex and deleveraging, creating a self-reinforcing discount. BAC and ALV have no direct read-through from the supplied information; avoid treating their inclusion as an exposure signal.

Key Decisions for Investors

• No immediate event-driven position based solely on this release; monitor GPGI liquidity, borrow availability, and the next quarterly filing for changes in pro forma leverage, goodwill/intangible balances, and Husky synergy guidance.
• Establish a conditional short/watch on GPGI only if management cuts acquired-business EBITDA or FCF guidance, reports material integration charges beyond prior expectations, or goodwill impairment indicators emerge. Size modestly given potential short interest and deal-related volatility; cover on a credible reaffirmation plus evidence of deleveraging.
• For existing GPGI longs, reduce exposure into the next results unless valuation already discounts a material impairment scenario. Thesis is falsified positively by sustained delivery versus acquisition targets, transparent purchase-accounting disclosure, and net-leverage reduction over the next two reporting periods.
• Do not use BAC or ALV as sympathy hedges. Reassess only if future filings identify financing, customer, supplier, or counterparty links not present in the current record.